NCT01485081View on ClinicalTrials.gov

Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in Side Branches of de Novo Bifurcation Lesions (DEBSIDE)

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2014

Conditions
Coronary Disease
Interventions
DEVICE

Danubio paclitaxel-eluting balloon

Inflation of the Danubio Paclitaxel Eluting Balloon in the side branch of a de novo bifurcation lesion.

Trial Locations (7)

31076

Clinique Pasteur, Toulouse

44093

CHU Nantes, Nantes

63003

CHU Clermont-Ferrand, Clermont-Ferrand

63050

Pôle Santé République, Clermont-Ferrand

76000

Clinique Saint-Hilaire, Rouen

78740

Centre Cardiologique d'Evecquemont, Évecquemont

91300

Institut hospitalier Jacques Cartier, Massy

All Listed Sponsors
collaborator

European Cardiovascular Research Center

NETWORK

lead

MINVASYS

INDUSTRY

NCT01485081 - Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in Side Branches of de Novo Bifurcation Lesions (DEBSIDE) | Biotech Hunter | Biotech Hunter